Variable | Pre-PSM Cohort | Post-PSM Cohort | ||||
---|---|---|---|---|---|---|
<63 Gy | ≥63Gy | P value | <63 Gy | ≥63Gy | P value | |
Total | 93 | 90 | Â | 59 | 59 | Â |
Gender | Â | Â | Â | Â | Â | Â |
 Male | 66 | 59 | 0.431 | 47 | 38 | 0.065 |
 Female | 27 | 31 | 12 | 21 |  | |
Age (years) | Â | Â | Â | Â | Â | Â |
 <60 years | 52 | 48 | 0.726 | 31 | 27 | 0.461 |
 ≥60 years | 41 | 42 | 28 | 32 |  | |
KPS Score | Â | Â | Â | Â | Â | Â |
 ≤80 | 58 | 52 |  | 32 | 32 |  |
 >80 | 35 | 38 | 0.526 | 27 | 27 | 1.000 |
Pathological type | Â | Â | Â | Â | Â | Â |
 Squamous carcinoma | 35 | 24 | 0.048 | 24 | 20 | 0.651 |
 adenocarcinoma | 47 | 61 | 30 | 35 |  | |
 Other | 11 | 5 |  | 5 | 4 |  |
T status | Â | Â | Â | Â | Â | Â |
 T1-2 | 33 | 36 | 0.529 | 19 | 22 | 0.562 |
 T3-4 | 60 | 54 | 40 | 37 |  | |
N status | Â | Â | Â | Â | Â | Â |
 N0-1 | 11 | 14 | 0.463 | 5 | 12 | 0.066 |
 N2-3 | 82 | 76 | 54 | 47 |  | |
Response to chemotherapy | Â | Â | Â | Â | Â | Â |
 Yes | 64 | 68 |  | 43 | 43 | 1.000 |
 No | 29 | 22 | 0.309 | 16 | 16 |  |
No. of chemotherapy cycles | Â | Â | Â | Â | Â | Â |
 <4 | 63 | 32 | <0.001 | 30 | 30 | 1.000 |
 ≥4 | 30 | 58 |  | 29 | 29 |  |
GTV volume (cm3) | Â | Â | Â | Â | Â | Â |
 <146 | 44 | 40 | 0.697 | 23 | 23 | 1.000 |
 ≥146 | 49 | 50 | 36 | 36 |  | |
Metastasis status | Â | Â | Â | Â | Â | Â |
 Single organ | 37 | 41 | 0.430 | 23 | 27 | 0.456 |
 2 to 3 organs | 56 | 49 | 36 | 32 |  |